These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7110328)

  • 1. Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive.
    Staunton DA; Magistretti PJ; Koob GF; Shoemaker WJ; Bloom FE
    Nature; 1982 Sep; 299(5878):72-4. PubMed ID: 7110328
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesolimbic dopamine neurons: effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats.
    Kelly PH; Moore KE
    Psychopharmacology (Berl); 1977 Nov; 55(1):35-41. PubMed ID: 414259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
    Creese I; Burt DR; Snyder SH
    Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.
    Mandel RJ; Wilcox RE; Randall PK
    Pharmacol Biochem Behav; 1992 Feb; 41(2):343-7. PubMed ID: 1574523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat.
    Swerdlow NR; Lee D; Koob GF; Vaccarino FJ
    J Pharmacol Exp Ther; 1985 Nov; 235(2):324-9. PubMed ID: 3932641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.
    Castellani S; Adams PM
    Neuropharmacology; 1981 Apr; 20(4):371-4. PubMed ID: 7197334
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra.
    Satoh H; Satoh Y; Notsu Y; Honda F
    Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol.
    Vogelsang GD; Piercey MF
    Eur J Pharmacol; 1985 Apr; 110(2):267-9. PubMed ID: 3987817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers.
    Köhler U; Schröder H; Augustin W; Sabel BA
    Neurosci Lett; 1994 Mar; 170(1):99-102. PubMed ID: 8041522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs.
    Durlach-Misteli C; Van Ree JM
    Eur J Pharmacol; 1992 Jun; 217(1):15-21. PubMed ID: 1397023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement.
    Kozlowski MR; Marshall JF
    Brain Res; 1980 Sep; 197(1):167-83. PubMed ID: 7397550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.